Skip to content

Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead Placement

Reduction in Fluoroscopy Radiation Exposure During Lead Implantation for Sacral Neuromodulation: A Randomized Prospective Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04527445
Enrollment
44
Registered
2020-08-26
Start date
2026-06-01
Completion date
2027-06-01
Last updated
2026-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overactive Bladder, Radiation Exposure, Urge Incontinence, Urgency-frequency Syndrome

Keywords

Sacral Neuromodulation, Fluoroscopy

Brief summary

Fluoroscopy is performed when placing a lead during a sacral neuromodulation procedure. During lead placement, subjects will receive either conventional or experimental fluoroscopic settings. The radiation exposure will be compared between the two groups.

Detailed description

Patients scheduled for lead implantation during sacral neuromodulation in the operating room and consent will be included in this study. Placement of the lead in the operating room with fluoroscopy is the standard of care in this procedure. Fluoroscopy is performed with a C-arm and there are settings that change the radiation exposure. Patients scheduled to undergo lead placement will be randomized to: a) the investigational (reduced radiation with fluoroscopic settings) or b. the control (conventional fluoroscopy). The surgeon can change fluoroscopy radiation exposure by changing C-arm settings from the reduced radiation to conventional fluoroscopic options. During the surgery, the surgeon may change the settings from reduced radiation (intervention) to conventional fluoroscopy (control) to safely place lead. The surgeon will use their judgment to optimally place lead and maintain safety during placement. Any deviation from randomization will be recorded. The intervention arm is defined: Reduced radiation fluoroscopy technique is performed by the C-arm set at 1 pulses-per-second and reduction of current. The control arm is defined: The standard of care in the conventional fluoroscopy, the C-arm is set at 30 pulses-per-second and the current set at the default.

Interventions

PROCEDUREReduced radiation fluoroscopy

See previous information about each arm

See previous information about each arm

Sponsors

Loma Linda University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

Subjects notified of the arm after the procedure is performed

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

* Patients undergoing lead implantation for sacral neuromodulation that have overactive bladder as defined by urinary urgency, frequency, nocturia with or without urgency incontinence.

Exclusion criteria

* neurogenic bladder, BMI \>40, or peripheral neuropathy.

Design outcomes

Primary

MeasureTime frameDescription
Radiation ExposureAt time of proceduremeasure radiation exposure, milligray (mGy)

Secondary

MeasureTime frameDescription
Optimal lead placementAt time of procedurebased on intraoperative motor response
Voiding log (Bladder Record)3 months after surgeryClinical Outcome
Clinical Outcome assessed by validated questionnaire3 months after surgery
Inoperative complicationsAt time of proceduresurgery complication
Operative timesAt time of procedureminutes

Countries

United States

Contacts

CONTACTForrest Jellison, MD
fjellison@llu.edu909 558-2830
PRINCIPAL_INVESTIGATORForrest Jellison, MD

Loma Linda University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026